Tiotropium + Procaterol vs Tiotropium + Placebo in COPD Patients
Status:
Terminated
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
Study compares the efficacy and safety of tiotropium + a beta agonist (procaterol) vs.
tiotropium alone among patients with moderate chronic obstructive pulmonary disease